Back to Results
First PageMeta Content
Pharmaceutics / Food safety / Good manufacturing practice / Pharmaceuticals policy / Drug Master File / Neuland / Food and Drug Administration / Contract manufacturing organization / Form FDA 483 / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology


Contacts: Neuland Laboratories Ltd. Swathi Kuricheti Communications Officer +[removed]
Add to Reading List

Document Date: 2013-10-17 03:37:23

Open Document

File Size: 286,48 KB

Share Result on Facebook

City

Frankfurt / Hyderabad / New York City / /

Company

National Stock Exchange / CPhI Worldwide / Bombay Stock Exchange / NEULAND LABS / Neuland Laboratories Ltd. / U.S. Media BLL Partners / /

Continent

Europe / /

Country

Germany / Japan / United States / India / /

/

Event

Company Listing Change / /

IndustryTerm

manufacturing services / contract manufacturing / quality manufacturing / pharmaceutical manufacturer / manufacturing facilities / pharmaceutical and biopharmaceutical executives / peptide manufacturing / active pharmaceutical ingredients / cGMP manufacturing facilities / manufacturing organizations / /

Organization

German Health Authority / FDA / European Union / /

Person

Sucheth R. Davuluri / /

/

Position

Life Science Leader / Swathi Kuricheti Communications Officer / Chief Executive Officer / /

Technology

API / /

URL

www.NeulandLabs.com / /

SocialTag